CAG
IDXX icon

Crestwood Advisors Group’s Idexx Laboratories IDXX Stock Holding History

Crestwood Advisors Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$890K Buy
1,691
+507
+43% +$284K 0.01% 340
2026
Q1 		$665K Buy
1,184
+116
+11% +$74.4K 0.01% 356
2025
Q4 		$723K Buy
1,068
+98
+10% +$66.7K 0.01% 322
2025
Q3 		$620K Buy
970
+110
+13% +$66.8K 0.01% 340
2025
Q2 		$461K Buy
860
+31
+4% +$14.8K 0.01% 362
2025
Q1 		$348K Buy
+829
New +$360K 0.01% 394
2024
Q4 		– Sell
-448
Closed -$226K – 467
2024
Q3 		$226K Buy
+448
New +$218K ﹤0.01% 410

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Crestwood Advisors Group's IDXX Position: Q2 2026 in Review

Crestwood Advisors Group increased its Idexx Laboratories (IDXX) stake by 43% in Q2 2026, buying an estimated $284K and bringing the position to 1,691 shares worth $890K. The position accounts for 0.01% of the portfolio, ranked #340.

Crestwood Advisors Group first reported a position in IDXX in Q3 2024 and has held it in 7 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Crestwood Advisors Group held 1,691 shares of Idexx Laboratories worth $890K as of Q2 2026.
  • Crestwood Advisors Group bought 507 Idexx Laboratories shares in Q2 2026, an estimated $284K.
  • Idexx Laboratories made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #340 holding.
  • Crestwood Advisors Group first reported a position in Idexx Laboratories in Q3 2024 and has held it in 7 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.